Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol-supplemented cardioplegia for organ injury biomarkers in on-pump cardiac surgery
PACTR202510667466311Phase 1Not yet recruiting
- Sponsor
- Sohag University
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of propofol in cardiac disease (3 arms), sponsored by Sohag University. Primary endpoint: Serial cardiac troponin T measurement. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
propofol
03
Conditions
cardiac disease
Beyond the preview
Go deeper on PACTR202510667466311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202510667466311.